4,239 results on '"Date A"'
Search Results
2. The Deep Space Radiation Probe: Development of a First Lunar Science Payload for Space Environment Studies and Capacity Building
3. Clinicopathological features and survival outcomes of resected lung adenosquamous carcinoma: results from a nationwide Japanese registry data
4. Heterogeneity and Wage Growth of Full-time Workers in Japan: An Empirical Analysis Using Micro Data
5. Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of Rare Kidney Diseases cohort
6. Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition
7. Epidemiological shifts in and impact of COVID-19 on streptococcal toxic shock syndrome in Japan: A genotypic analysis of group A Streptococcus isolates
8. Surgical Strategy on Lung Transplantation for Kartagener’s Syndrome
9. Is Chronic Lung Allograft Dysfunction More Common After Lung Transplantation for Pulmonary Complications of Hematopoietic Stem Cell Transplantation?
10. Advancing apoptosis induction in triple negative breast cancer: Empowering treatment with tyrosine-stapled mixed micelles of lapatinib
11. Evidence of Alloimmune Activation Early After Lung Transplantation and its Impact on Graft Survival
12. Does HLA Mismatch Between Donors and Recipients Influence Postoperative Outcomes in Cadaveric Lung Transplants?
13. Blockade of ICAM-1 and LFA-1 Early After Transplantation Prevents Acute Cellular Rejection and Fibrotic Progression in Allogeneic Murine Lung Transplantation Model
14. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort
15. Bilateral Lung Transplantation For Pulmonary Emphysema Associated With Cutis Laxa
16. COMPARING ACTIVE SURVEILLANCE AND WATCHFUL WAITING AND RADICAL TREATMENT USING MACHINE LEARNING MODELS AMONG PROSTATE CANCER PATIENTS
17. Unlocking apoptosis in triple negative breast cancer: Harnessing “glutamine trap” to amplify the efficacy of lapatinib-loaded mixed micelles
18. Beta band functional connectivity increases prior to dream enactment behavior in patients with idiopathic/isolated REM sleep behavior disorder
19. Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry Database
20. Beneficial effects of extracorporeal membrane oxygenation over cardiopulmonary bypass in living-donor lobar lung transplantation
21. Postural balance control interventions in autism spectrum disorder (ASD): A Systematic Review
22. Fluorescence microscopy findings of ICG fluorescence localization at the tumor marking site in laparoscopic surgery for gastric cancer
23. Comparison of the safety and cost-effectiveness of nebulized liposomal amphotericin B and amphotericin B deoxycholate for antifungal prophylaxis after lung transplantation
24. Successful lung-sparing carinal reconstruction after induction chemoradiotherapy for carinal cancer via median sternotomy: Reefing bronchial membrane technique
25. Analyses of Effect of Foil Thickness on Fracture Mechanism of Foil
26. Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy
27. RIFM fragrance ingredient safety assessment, 2-sec-butylcyclohexanone, CAS Registry Number 14765-30-1
28. Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms
29. RIFM fragrance ingredient safety assessment, geranyl propionate, CAS Registry Number 105-90-8
30. RIFM fragrance ingredient safety assessment, 2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)-2-butenal, CAS registry number 3155-71-3
31. Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin
32. Taking the leap toward human-specific nonanimal methodologies: The need for harmonizing global policies for microphysiological systems
33. RIFM fragrance ingredient safety assessment, isoamyl isovalerate, CAS registry number 659-70-1
34. RIFM fragrance ingredient safety assessment, 11-oxahexadecanolide, CAS Registry Number 3391-83-1
35. Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer
36. Update to RIFM fragrance ingredient safety assessment, isodecyl alcohol, CAS Registry Number 25339-17-7
37. RIFM fragrance ingredient safety assessment, α-methylbenzyl isobutyrate, CAS Registry Number 7775-39-5
38. Instantaneous nondestructive evaluation of elastic modulus by using knocking ball test on sedimentary and metasedimentary rock slope
39. RIFM fragrance ingredient safety assessment, methyl sorbate, CAS Registry Number 689-89-4
40. RIFM fragrance ingredient safety assessment, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol, CAS Registry number 28219-61-6
41. Phase-Engineered Heterostructures of Mo2C by Plasma-Assisted Selenization and Sulfurization Processes Toward Excellent Hydrogen Evolution Reaction
42. RIFM fragrance ingredient safety assessment, ethyl valerate, CAS Registry Number 539-82-2
43. RIFM fragrance ingredient safety assessment, 3-methyl-2,4-nonedione, CAS Registry Number 113486-29-6
44. RIFM fragrance ingredient safety assessment, 2,6,10-trimethylundeca-5,9-dienol, CAS Registry Number 24048-14-4
45. Impact d’une exposition nocturne à la lumière bleue pendant l’adolescence sur le système circadien à l’âge adulte, d’un rongeur diurne Arvicanthis ansorgei
46. RIFM fragrance ingredient safety assessment, 3-methyl-2-buten-1-ol, CAS registry number 556-82-1
47. RIFM fragrance ingredient safety assessment, acetyl cedrene, CAS Registry Number 32388-55-9
48. RIFM fragrance ingredient safety assessment, 1-(4-hydroxy-3-methoxyphenyl)decan-3-one, CAS registry number 27113-22-0
49. RIFM fragrance ingredient safety assessment, cyclohexaneethanethiol, 3-mercapto-b,4-dimethyl-, CAS Registry Number 4802-20-4
50. RIFM fragrance ingredient safety assessment, 4-hydroxy-3-pentenoic acid lactone, CAS Registry number 591-12-8
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.